Filter
512
Filtered Results: 512
Text search:
rubella
Featured
Recommendations
49
New Publications
174
Language
Document type
No document type
283
Guidelines
72
Studies & Reports
69
Manuals
21
Strategic & Response Plan
21
Fact sheets
16
Situation Updates
12
Infographics
6
Brochures
5
Training Material
4
Resource Platforms
2
Online Courses
1
Countries / Regions
Bangladesh
21
Global
20
Nepal
17
Latin America and the Carribbean
14
India
14
Germany
13
Myanmar / Burma
13
Paraguay
12
Ukraine
11
South Africa
10
Sierra Leone
9
Philippines
9
Western and Central Europe
9
Zambia
9
Nigeria
8
Venezuela
8
Namibia
8
Kenya
7
Lesotho
7
Rwanda
6
Africa
6
Tanzania
6
South–East Asia Region
5
Bolivia
5
Indonesia
5
Congo, Democratic Republic of
4
Argentina
4
Brazil
4
South Sudan
4
Liberia
4
Colombia
3
Ghana
3
Malawi
3
Mozambique
3
East and Southern Africa
3
Uganda
3
Russia
3
Ethiopia
3
Botswana
3
Chile
2
Cameroon
2
Syria
2
Albania
2
Peru
2
Zimbabwe
2
Jordan
2
Middle East and North Africa
2
Lebanon
2
Eastern Europe
2
Yemen
2
Mali
2
Libya
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Mexico
1
Turkey
1
Togo
1
Senegal
1
Burkina Faso
1
Afghanistan
1
Bulgaria
1
Haiti
1
Cambodia
1
West and Central Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Jamaica
1
Latvia
1
Vietnam
1
Papua New Guinea
1
Egypt
1
Sudan
1
Central African Republic
1
Angola
1
Bhutan
1
Iraq
1
Ecuador
1
Solomon Islands
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
228
Clinical Guidelines
59
Women & Child Health
32
Public Health
22
Key Resources
19
Capacity Building
4
Pharmacy & Technologies
4
Toolboxes
COVID-19
55
Rapid Response
37
Refugee
30
Disability
25
Zika
22
Mental Health
17
Conflict
15
HIV
13
Pharmacy
11
Ebola & Marburg
10
NTDs
10
Caregiver
8
NCDs
7
TB
6
Malaria
6
Polio
6
AMR
6
Health Financing Toolbox
5
Natural Hazards
3
Planetary Health
3
2.0 Rapid Response
2
Global Health Education
1
The Committee examined the clinical development of Ebola virus vaccines and conducted an inventory of available data on their safety. It also reviewed 3 generic issues: updating a global strategy on vaccine safety, use of a network of distributed data ...
Recommendations for the adaptation of Emergency Medical Teams (EMTs) at temporary sites for COVID-19 vaccination. Draft Version 2.3, November 2021
In 2017, $37.4 billion of development assistance was provided to low- and middleincome countries to maintain or improve health. This amount is down slightly compared to 2016, and since 2010, development assistance for health (DAH) has grown at an annualized rate of 1.0%. While global development ass...
Neurological, Psychiatric, and Developmental Disorders: Meeting the Challenge in the Developing World
Institute of Medicine (US) Committee on Nervous System Disorders in Developing Countries.
Washington (DC): National Academies Press (US); 2001.
Practical Guide to Mental Health Problems
recommended
This 88 page book is designed to help primary care workers understand mental health problems and how they can be treated. Mental health problems from childhood to old age are examined. The book focuses primarily on the Afghan culture but is also relevant to a wider community
Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019
Recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America and the Pediatric Infectious Diseases Society
(This g...
The African Centers for Disease Control and Prevention and the African Union together have called for a New Public Health Order which will safeguard the health and economic security of the continent as it strives to meet the aspirations of the Agenda 2063. A key pillar of this mandate seeks to expan...
Communicable Disease Control Branch
Communicable Disease Management Protocol – Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS), February 2010
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future...
